Assessment of adverse events of the novel antiepileptic drug lamotrigine: a real-world pharmacovigilance study based on FAERS
Our analysis in the post-marketing setting reveals new AE signals associated with LTG, highlighting the need for ongoing risk surveillance.
Authors
- Longxiang Tu
- Ying Tu (ORCID: https://orcid.org/0000-0001-7770-9876)
- Quan Hong (ORCID: https://orcid.org/0000-0002-6839-7695)
- Shuping Wang (ORCID: https://orcid.org/0000-0002-2397-5084)
- Jingyang Xiao
- Aijun Ouyang
Institutions
- Nanchang University (CN)
- First Affiliated Hospital of Jiangxi Medical College (CN)
- Shenzhen Maternity and Child Healthcare Hospital (CN)
- Second Affiliated Hospital of Nanchang University (CN)
- First Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2025-02-18
- DOI
- https://doi.org/10.1080/14740338.2025.2465867
- Citations
- 4
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 5.23
Funders
- Natural Science Foundation of Hubei Province